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The neuronal and smooth muscle effects of methanol extract prepared from the air-dried flowering aerial parts of Sideritis montana L. (SEM) was tested in 
vitro on guinea-pig ileum. The chemical composition of the investigated extract was analysed by HPLC-MS, and chrysoeriol, chlorogenic acid and caffeic acid 
were detected as main constituents. The isolated organ assay showed that S. montana extract caused an immediate contraction and a more slowly developing 
inhibitory response in the ileum. The SME-induced contractions were strongly inhibited by the acetylcholine muscarinic receptor antagonist atropine (0.5 µM), 
but not by the Na+ channel blocker tetrodotoxin (TTX; 0.5 µM) or the histamine H1 receptor antagonist chloropyramine (0.5 µM). Selective desensitization of 
capsaicin-sensitive neurons by the sensory neuron stimulant and blocker capsaicin did not influence the contractile effect of SME. As to the spasmolytic effect, 
SME inhibited the effects of electrical field stimulation, exogenous acetylcholine, or histamine. These smooth muscle-relaxing effects were reversible by 
repeated renewals of the bathing solution in 40 min. 
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Sideritis montana L. belongs to the family Lamiaceae, genus 
Sideritis. The genus Sideritis comprises more than 150 perennial 
and annual species, most of them grow in the Mediterranean area 
[1], but some species are also found in Germany and Western China 
[2]. 
 
Sideritis species are commonly known as ”mountain tea”. The 
decoctions or the infusions of aerial parts are traditionally used in 
Mediterranean folk medicine against different diseases, infections 
and injuries, because of their anti-inflammatory [3], analgesic [4], 
antitussive, spasmolytic [5], antimicrobial [6], anticonvulsant [7], 
antiulcerative [8], and wound-healing [2] effects. Different extracts 
and fractions, and isolated compounds, such as diterpenoids [9], 
phenylpropanoid glycosides [10] and flavonoids [11] were 
investigated to validate their use in folk medicine. These studies 
have shown anti-inflammatory, antioxidant, antiulcerative, 
analgesic and antimicrobial activities [2,12,13]. Some diterpenoids 
isolated from Sideritis ssp, and their semisynthetic derivatives 
showed anti-HIV activity [2]. Different extracts possessed 
antiproliferative, selective estrogen modulatory and antiherpetical 
activity [2]. 
 
The typical chemical constituents of the Sideritis genus are 
flavonoids [14,15], iridoids [16], coumarins, lignanes [17], 
phenylpropanoid glycosides [18], and sterols [19]. Almost every 
species of the Sideritis genus contain diterpenes [20], flavonoids 
[21], and essential oil [22,23], and with regard to the literature data, 
these constituents are responsible for the main pharmacological 
activities. 
 
The aim of this study was to evaluate the effect of S. montana 
methanolic extract (SME) on the motor responses of the ileum of 
the guinea-pig and to determine the possible mechanisms 
encountered. The chemical composition of the investigated plant 
extract was characterized by HPLC-MS. 
A methanol extract from the air-dried aerial parts of S. montana was 
prepared. The HPLC-MS analysis of the extract revealed the 
presence of phenolic compounds, the flavonoid chrysoeriol and 
phenolic acids, chlorogenic acid and caffeic acid (Figure 1). These 
compounds were detected previously from some Sideritis species 
[24], but chlorogenic acid and caffeic acid were identified for the 
first time from S. montana. Previously only the components of the 
essential oil and seeds of this plant were reported besides 
chrysoeriol [25]. 
 
Figure 1: MRM spectra of the S. montana methanol extract. For clarity only one ion 
transition was illustrated for all components (353→191 for chlorogenic acid, 179→135 
for caffeic acid and 299→256 for chrysoeriol).  
 
The pharmacological investigation of S. montana methanolic extract 
(SME) showed that it caused an immediate contraction and a more 
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slowly developing inhibitory response in the ileum. Contraction in 
response to 2 mg/mL of SME was not reproducible upon repeated 
administration (n=4) and anyway this amount yielded a too high 
DMSO concentration in the organ bath, therefore a standard 
concentration of 1 mg/mL was used, whose action proved to be 
reproducible with contact times of 3 min and a washout period of 
40 min between the two administrations. For assessing 
concentration-effect relationship, lower concentrations were also 
tested (Table 1). At none of the corresponding volumes of 
administration did the solvent (DMSO) cause a contraction 
exceeding 5% of the maximal spasm. 
 
Table 1: Contractile effects of different concentrations of S. montana extract (SME) on 
the guinea-pig small intestine.  
 
Sample %  SD n 
SME 0.33 mg/mL 18.1 ± 8.82 6 
SME 0.66 mg/mL 27.6 ± 11.94 11 
SME 1.00 mg/mL, 1st administration 28.6 ± 5.03 7 
SME 1.00 mg/mL, 2nd administration 31.8 ± 6.88 7 
1 mg/mL in two successive administrations were performed (each for 3 min), separated 
by a 40 min washout period. Contractions are expressed as % of the maximal 
longitudinal spasm in response to histamine (10 μM). 
 
Pharmacological analysis has shown that SME-induced contractions 
were strongly inhibited by the acetylcholine muscarinic receptor 
antagonist atropine (0.5 µM; Table 2), but not by the Na+ channel 
blocker (nerve conduction inhibitor) tetrodotoxin (TTX; 0.5 µM) or 
the histamine H1 receptor antagonist chloropyramine (0.3 µM) 
(Table 2). Likewise, the sensory neuron stimulant and blocker 
capsaicin (1 μM, administered for 50 min) failed to inhibit the effect 
of SME. Capsaicin caused an immediate excitation, then a more 
delayed inhibition [26], but at the time of SME administration it had 
no effect on either basal tone or the electrically-evoked cholinergic 
contractions, while the preparation was totally unresponsive to 
capsaicin itself (tested in separate experiments, n=5). 
 
Table 2: Effects of drug pretreatments on the SME-induced contractile response. 
(Expression of the results, see Table 1.)  
 
Sample %  SD* n 
SME (1 mg/mL) before atropine 30.3 ±5.39 
6 
SME (1 mg/mL) in the presence of atropine 6.7 ± 5.63 
SME (1 mg/mL) before tetrodotoxin (TTX) 30.1 ± 9.17 
5 
SME (1 mg/mL) in the presence of TTX 31.1 ± 3.80 
SME (1 mg/mL) before chloropyramine 34.3 ± 2.68 
5 
SME (1 mg/mL) in the presence of chloropyramine 30.8 ± 5.59 
SME (1 mg/mL) before capsaicin 30.9 ± 4.25 
5 
SME (1 mg/mL) in the presence of capsaicin 32.4 ± 9.17 
*p < 0.05 or less. Concentrations of drugs were 0.5 μM for atropine and tetrodotoxin 
(contact time, 20 min), 0.3 μM for chloropyramine (contact time, 20 min) and 1 μM for 
capsaicin (administered for 50 min, with rinsing and readministering capsaicin at min 
15 and 30). Before the first administration of SME the solvents of the respective drug 
was administered (0.5 μL/mL ethanol for capsaicin and 1 μl/mL isotonic saline for the 
rest of the drugs). 
 
SME (0.33−1 mg/mL or 0.1−1 mg/mL, administered for 20 min) 
concentration-dependently inhibited the effects of electrical field 
stimulation, exogenous acetylcholine, or histamine (Tables 3−5). 
These effects were reversible by repeated renewals of the bathing 
solution in 40 min (data not shown). 
 
Table 3: Effects of different concentrations of SME (contact time 20 min) on the 
cholinergic twitch response evoked by single shocks of electrical field stimulation. 
(Expression of the results, see Table 1.) 
 
Sample %  SD* n 
Twitch response before 52.0 ± 9.31 
6 
In the presence of SME (0.33 mg/mL) 43.5 ± 13.72 
Twitch response before 58.2 ± 17.54 
8 
In the presence of SME (0.66 mg/mL) 46.0 ± 11.88 
Twitch response before 52.4 ± 20.91 
13 
In the presence of SME (1.00 mg/mL) 30.8 ± 17.31 
*p < 0.05 or less. Responses before SME administration were evoked while the 
respective amount of DMSO was present in the organ bath. (DMSO usually caused 
slight enhancement of the twitch response.) SME was administered for 10 min first, 
then removed by rinsing and immediately readministered. Electrical stimulation was 
stopped for the first 10 min of SME administration. In this way, the initial contractile 
response to SME did not interfere with the effect of field stimulation. 
Table 4: Effects of different concentrations of SME (contact time, 20 min) on the 
acetylcholine (ACh, 0.1 μM) -evoked contractile response. (Expression of the results, 
see Table 1.)  
 
Sample %  SD* n 
Effect of ACh before  72.1 ± 11.40 
5 
In the presence of SME (0.10 mg/mL) 66.9 ± 12.30 
Effect of ACh before 75.0 ± 8.82 
6 
In the presence of SME (0.33 mg/mL) 47.1 ± 15.92 
Effect of ACh before 71.6 ± 11.27 
6 
In the presence of SME (0.66 mg/mL) 41.2 ± 7.59 
Effect of ACh before 66.8 ± 14.82 
7 
In the presence of SME (1.00 mg/mL) 15.9 ± 3.17 
*p < 0.05 or less. Responses before SME administration were evoked while the 
respective amount of DMSO was present in the organ bath. SME was administered for 
10 min first, then removed by rinsing and immediately readministered for another 
10 min. 
 
Table 5: Effects of different concentrations of SME on the histamine (0.3 μM) -evoked 
contractile response. (Expression of the results, see Table 1.) 
 
Sample %  SD* n 
Effect of histamine before 60.7 ± 12.98 
6 
In the presence of SME (0.33 mg/mL) 59.5 ± 18.13 
Effect of histamine before 60.2 ± 17.46 
7 
In the presence of SME (0.66 mg/mL) 45.8 ± 10.58 
Effect of histamine before 64.0 ± 7.10 
6 
In the presence of SME (1.00 mg/mL) 34.3 ± 16.90 
*p < 0.05 or less. Responses before SME administration were evoked while the 
respective amount of DMSO was present in the organ bath. SME was administered for 
10 min first, then removed by rinsing and immediately readministered for another 
10 min. 
 
These results indicate that the effect of SME on the small intestine 
exerts two kinds of effect: concentration-dependent contraction and 
relaxation of the smooth muscle, quicker and slower in 
development, respectively. 
 
The SME-induced contraction seems not to involve nerve axonal 
conduction (spike generation through voltage-dependent Na+ 
channels), as shown by the lack of effect of TTX. Also histamine-
like contractile activity was not involved, since the histamine H1 
receptor antagonist chloropyramine did not inhibit the contractile 
effect of SME. The concentrations of TTX and chloropyramine 
used are sufficient to fully block the effect of electrical field 
stimulation of nerves and of histamine (0.3 μM), respectively, as 
shown by earlier experiments (n > 50 and n=15, respectively) [26]. 
 
The inhibitory effect of the muscarinic acetylcholine receptor 
antagonist atropine on the SME-induced contraction indicates the 
involvement of such receptors in this response. We basically see 
two possibilities for the interpretation of this result. First, SME 
itself may possess acetylcholine-like activity, i.e., it stimulates 
muscarinic receptors directly. Second, endogenous acetylcholine is 
released from the preparation by SME. Within the gut wall, nerve 
endings of neuronal plexus neurons are the most probable source of 
this biogenic amine. In this case acetylcholine is most probably 
released by a mechanism independent of Na+ channels, i.e. spike 
generation, as shown by the lack of effect of TTX. It is known that 
nerve endings (unlike axons) are mostly resistant to the effect of 
TTX. 
 
The sensory stimulant capsaicin causes cholinergic (atropine-
sensitive) contraction in the guinea-pig small intestine. Although 
this response is strongly attenuated by TTX [26] and therefore only 
partly mimics that of SME, we tested the effect of capsaicin 
desensitization on the SME-induced contraction. Capsaicin 
exposure is able to selectively block the effect of capsaicin itself by 
rendering capsaicin-sensitive nerve endings functionally impaired 
[26]. A long exposure of the preparations was used to a moderate 
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concentration of capsaicin. At the end of this incubation (without 
removing capsaicin from the organ bath) the preparations were 
insensitive to capsaicin, whereas the effect of electrical field 
stimulation was unimpaired, as shown by preliminary experiments 
[26]. This procedure failed to inhibit the excitatory action of SME, 
indicating no involvement of capsaicin-sensitive nerves. 
 
Upon longer incubation SME showed inhibitory effects on 
contractions evoked by electrical field stimulation of cholinergic 
nerves, exogenous ACh, or histamine. Although concentration-
inhibition curves of SME against these contractile influences were 
not fully superposable, the differences in the inhibitory effects make 
less than one order of magnitude; consequently, we think that they 
all are manifestations of a non-selective smooth muscle-relaxant 
effect of SME. 
 
The spasmolytic effect of chrysoeriol was previously detected on 
isolated rat jejunum. This compound at 30 μg/mL concentration 
antagonised non-competitively the concentration-response curve 
induced by CaCl2 (Emax = 70.0%) [27]. Another investigation 
resulted that the spasmolytic effect of chrysoeriol mediated possibly 
through K+ channel opening action [28]. Moreover, the spasmolytic 
activity of aqueous extract of Lippia integrifolia was also 
demonstrated and confirmed that the high caffeoyl quinic acid (one 
of them is chlorogenic acid) content (0.10 %) could be responsible 
for this effect [29]. The detected compounds could be, at least 
partly, responsible for the spasmolytic effect of S. montana 
methanol extract which can evolve through different 
pharmacological mechanisms. 
 
Taken together, these data indicate an acetylcholine-like excitatory 
and a non-selective smooth muscle relaxant effect of S. montana 
extract. 
 
Experimental 
 
Plant material: Sideritis montana L. was collected near Öskü 
(Hungary), in July 2013. Botanical identification was carried out by 
one of the authors, Gyula Pinke (Department of Botany, Faculty of 
Agricultural and Food Sciences, University of West Hungary). A 
voucher specimen (No. 822) has been deposited at the Herbarium of 
the Department of Pharmacognosy, University of Szeged, Szeged, 
Hungary. 
 
Preparation of the extract: The extract was prepared from 50 g 
air-dried, powdered plant material with 3 × 500 mL MeOH with the 
use of an ultrasonic bath for 3 × 15 min. After filtration, the 
solutions were combined and evaporated to dryness (5.9 g) under 
reduced pressure. 
 
HPLC-MS apparatus and measurement conditions: 
Chromatographic separation of S. montana methanol extract was 
performed using a Shimadzu liquid chromatographic system [2 
pumps (LC-20AD); diode array detector (SPD-M20A)]; 
Autosampler (SIL-20A); Controller (CBM-20A); Degasser (DGU-
20A3); Column thermostat (CTO-20AC) equipped with a 
LiChrospher 100 RP-18e (4 mm × 250 mm, 5 µm) column. Mobile 
phase A was 0.1% formic acid in acetonitrile and mobile phase B 
was 0.1% formic acid in water. Gradient elution was applied 
(0 min: 95% mobile phase B; 12 min: 70% mobile phase B; 40 min: 
40% mobile phase B; 50 min: 0% mobile phase B; 51 min: 95% 
mobile phase B; 61 min: 95% mobile phase B).The flow rate was 
600 µL/min. The HPLC was coupled to an API 2000 MS/MS with 
an electrospray (ESI) interface. The source temperature was 300 °C. 
The measurements were carried out in negative ionization mode and 
the qualification was accomplished by using multiple reaction 
monitoring (MRM) with transitions of m/z 179→135 and 179→107 
for caffeic acid, m/z 353→191 and 353→179 for chlorogenic acid 
and m/z 299→284 and 299→256 for chrysoeriol. Data aquisition 
and evaluation were performed using Analyst 1.5.1 software. 
 
Animals and assay arrangement: All experiments have been 
approved by the Regional Committee for Animal Research 
(Baranya County, Hungary), approval number, BA02/2000-1/2012. 
Guinea-pigs (short-haired, coloured, 420-600 g) of either sex were 
killed by a blow to the occiput and bled out. Preterminal ileal 
segments were removed, gently flushed with Krebs-Henseleit 
solution and placed into a Petri dish. Longitudinally-oriented 
preparations of approximately 3 cm length were placed into 5 mL 
organ baths containing Krebs-Henseleit solution of 37 °C, bubbled 
with a mixture of 95% O2 and 5% CO2. Movements were recorded 
isotonically, by means of lever transducers and bridge amplifiers 
(Hugo Sachs−Harvard Apparatus, March−Hugstetten, Germany), 
under a constant tension, which was 6 mN. Experiments started 
after an equilibration period of 30 min. Histamine (10 μM) was then 
administered for 1.5 min for evoking maximal longitudinal spasm. 
After another 30 min of washout submaximal gut contractions were 
evoked by electrical field stimulation [30] or by administering 
acetylcholine (0.1 μM for 1 min) or histamine (0.3 μM for 1 min). 
Cholinergic “twitch” responses of approximately half-maximal size 
were evoked by electrical field stimulation (near-maximal voltage 
of 15 V/cm, 0.1 ms pulse width, single electrical shocks at 0.05 Hz), 
applied by means of a high-performance stimulator (Experimetria, 
Budapest, Hungary), through a pair of platinum wire electrodes, 
placed at the top and the bottom of the organ bath. The experiments 
with histamine were performed while the muscarinic acetylcholine 
receptor antagonist atropine (0.5 μM) was present in the organ bath. 
 
Drugs and solutions: Composition of the bathing solution was as 
follows NaCl 119 mM, NaHCO3 25 mM, KCl 2.5 mM, MgSO4 
1.5 mM, CaCl2 2.5 mM, KH2PO4 1.2 mM, glucose 11 mM. Drugs 
used were acetylcholine chloride, atropine sulfate, capsaicin, 
histamine hydrochloride, tetrodotoxin (Sigma), chloropyramine 
(Egis Pharmaceutical Company, Budapest). Capsaicin (2 mM) was 
dissolved in ethanol; the rest of drugs was dissolved and diluted in 
isotonic saline. S. montana extract was dissolved in DMSO, at a 
concentration of 0.33 g/mL; higher concentrations could not be 
prepared. 
 
Statistical analysis: Data are indicated as mean ± SD. For 
comparing responses before and after drug treatment, Wilcoxon’s 
signed rank test was used. A value of p < 0.05 or smaller was taken 
as significant. 
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